A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/195 (2006.01) A61K 9/00 (2006.01) A61K 9/20 (2006.01) A61K 31/197 (2006.01)
Patent
CA 2449009
A method of concurrent treatment for gastroesophageal reflux disease and nocturnal acid breakthrough is described, which comprises the delivery of an GABAb receptor agonist such as 4-amino-3-(4-chlorophenyl) butanoic acid, in the evening, in a gastric retained drug delivery system.
L'invention concerne une méthode permettant de traiter concurremment un reflux gastroesophagien pathologique et une sécrétion d'acide nocturne, consistant à administrer un agoniste du récepteur de GABAb, notamment de l'acide 4-amino-3-(4-chlorophényl) butanoïque, le soir, à l'aide d'un système d'administration d'un médicament retenu dans l'estomac.
Berner Bret
Cowles Verne E.
Fara John W.
Depomed Development Ltd
Fetherstonhaugh & Co.
LandOfFree
Method of treating gastroesophageal reflux disease and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating gastroesophageal reflux disease and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating gastroesophageal reflux disease and... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1391356